An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II)

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 124, Issue 3, 2017, Pages 453-461

  van Baaren, G J ^a   Broekhuijsen, K ^b   van Pampus, M G ^c   Ganzevoort, W ^a   Sikkema, J M ^d   Woiski, M D ^e   Oudijk, M A ^a   Bloemenkamp, K W M ^f,g   Scheepers, H C J ^h   Bremer, H A ⁱ   Rijnders, R J P ^j   van Loon, A J ^k   Perquin, D A M ^l   Sporken, J M J ^m   Papatsonis, D N M ⁿ   van Huizen, M E ^o   Vredevoogd, C B ^p   Brons, J T J ^q   Kaplan, M ^r   van Kaam, A H ^s   Groen, H ^b   Porath, M ^t   van den Berg, P P ^b   Mol, B W J ^u   Franssen, M T M ^b   Langenveld, J ^v   more..

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^d ZGT Almelo ^*  (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h MAASTRICHT UNIVERSITY   (Netherlands)

ⁱ REINIER DE GRAAF HOSPITAL   (Netherlands)

^j JEROEN BOSCH HOSPITAL   (Netherlands)

^k MARTINI HOSPITAL   (Netherlands)

^l MEDICAL CENTER LEEUWARDEN   (Netherlands)

^m CANISIUS WILHELMINA HOSPITAL   (Netherlands)

ⁿ AMPHIA HOSPITAL   (Netherlands)

^o HAGA HOSPITAL   (Netherlands)

^p MEDICAL CENTER HAAGLANDEN   (Netherlands)

^q MEDISCH SPECTRUM TWENTE   (Netherlands)

^r Röpcke Zweers Hospital Hardenberg   (Netherlands)

^s EMMA CHILDREN S HOSPITAL   (Netherlands)

^t MÁXIMA MEDICAL CENTER   (Netherlands)

^u UNIVERSITY OF ADELAIDE   (Australia)

^v Sittard Geleen Heerlen   (Netherlands)

more..

Author keywords

Economic evaluation; expectant monitoring; hypertensive disorders; immediate delivery; preterm

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EXPECTANT MONITORING; FEMALE; GESTATIONAL AGE; HEALTH CARE COST; HOSPITAL DISCHARGE; HUMAN; IMMEDIATE DELIVERY; MATERNAL HYPERTENSION; NETHERLANDS; NEWBORN; OBSTETRIC DELIVERY; OUTCOME ASSESSMENT; OXYGEN SUPPLY; PATIENT MONITORING; PREVALENCE; RESPIRATORY DISTRESS SYNDROME; CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; LABOR INDUCTION; MULTICENTER STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA; WATCHFUL WAITING;

COST-BENEFIT ANALYSIS; FEMALE; GESTATIONAL AGE; HEALTH CARE COSTS; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, NEWBORN; LABOR, INDUCED; NETHERLANDS; PREGNANCY; PREGNANCY OUTCOME; RESPIRATORY DISTRESS SYNDROME, NEWBORN; WATCHFUL WAITING;

EID: 84960358761     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.13957     Document Type: Article

References (21)

1. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 2013;170:1–7.
2. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011;25:391–403.
3. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130–7.
4. Simon J, Gray A, Duley L. Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial. BJOG 2006;113:144–51.
5. Teune MJ, Bakhuizen S, Gyamfi BC, Opmeer BC, van KA, van Wassenaer AG, et al. A systematic review of severe morbidity in infants born late preterm. Am J Obstet Gynecol 2011;205:374.e1–9.
6. Mishanina E, Rogozinska E, Thatthi T, Uddin-Khan R, Khan KS, Meads C. Use of labour induction and risk of cesarean delivery: a systematic review and meta-analysis. CMAJ 2014;186:665–73.
7. Koopmans CM, Bijlenga D, Aarnoudse JG, van Beek E, Bekedam DJ, van den Berg PP, et al. Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial. BMC Pregnancy Childbirth 2007;7:14.
8. Langenveld J, Broekhuijsen K, van Baaren GJ, van Pampus MG, van Kaam AH, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial. BMC Pregnancy Childbirth 2011;11:50.
9. Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009;374:979–88.
10. Vijgen SM, Koopmans CM, Opmeer BC, Groen H, Bijlenga D, Aarnoudse JG, et al. An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial). BJOG 2010;117:1577–85.
11. Broekhuijsen K, van Baaren GJ, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, et al. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet 2015;385:2492–501.
12. Drummond MF, Sculpher MJ, Torrance GW, O'Brien B, Stoddart GL. Methods for the Economic Evalution of Health Care Programmes, 3rd edn. Oxford, UK: Oxford University Press, 2005.
13. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. Oxford, UK: Oxford University Press, 1996.
14. Netherlands S. Statline Consumer Pricing index. [www.statline.nl]; 2008.
15. Hakkaart- van Roijen L, Tan SS, Bouwmans CAM. Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. College voor zorgverzekeringen (CvZ) [Health Insurance Board], Diemen, 2010.
16. Nederlandse zorgautoriteit [Dutch Health Authority Tariff]. http://www.nza.nl/regelgeving/tarieven. Accessed 31 December 2014.
17. Pharmacotherapeutic Compass 2011. College voor zorgverzekeringen (CvZ) [Health Insurance Board], 2011.
18. Black WC. The CE plane: a graphic representation of cost-effectiveness. Med Decis Making 1990;10:212–4.
19. Teune MJ. Long-term child follow-up after large obstetric randomised controlled trials for the evaluation of perinatal interventions: a systematic review of the literature. BJOG 2013;120:15–22.
20. Mangham LJ, Petrou S, Doyle LW, Draper ES, Marlow N. The cost of preterm birth throughout childhood in England and Wales. Pediatrics 2009;123:e312–27.
21. van Baaren GJ, Jozwiak M, Opmeer BC, Oude Rengerink K, Benthem M, Dijksterhuis MG, et al. Cost-effectiveness of induction of labour at term with a Foley catheter compared to vaginal prostaglandin E(2) gel (PROBAAT trial). BJOG 2013;120:987–95.